Status of diabetes care in elderly diabetic patients of a developing country

Iranian Journal of Diabetes and Lipid Disorders

Volumn 10, Issue , 2011, Pages 1-8

  Tabatabaei Malazy, Ozra ^a   Peimani, Maryam ^a   Heshmat, Ramin ^a   Pajouhi, Mohammad ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Diabetes; Diabetes care status; Elderly; Iran

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT; SUGAR;

ADULT; AGED; AGING; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; BODY MASS; CLINICAL EVALUATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DEVELOPING COUNTRY; DIABETES MELLITUS; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; DIET; DYSLIPIDEMIA; ELDERLY CARE; FAMILY HISTORY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEUROPATHY; PRESCRIPTION; RETROSPECTIVE STUDY; SMOKING; SYSTOLIC BLOOD PRESSURE;

EID: 81855200107     PISSN: 17267544     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. The World Health Report 1997-conquering suffering, enriching humanity. World Health Forum. 1997; 18(3-4):248-60.
2. Khatib O, Tabatabaei-Malazy O. Prevention and public approach to diabetic foot. Iranian Journal of Diabetes and Lipid Disorders 2007; 7:1.
3. Khatib O. Guidelines for the prevention, management and care of diabetes mellitus. World Health Organization, EMRO Technical Publications Series. 2006; 32:1-82.
4. Abbaszadeh Ahranjani S, Tabatabaei-Malazy O, Pajouhi M. Diabetes in old age, a review. Iranian Journal of Diabetes and Lipid Disorders 2009:113-28.
5. Glatthaar C, Welborn T, Stenhouse N, Garcia-Webb P. Diabetes and impaired glucose tolerance. A prevalence estimate based on the Busselton 1981 survey. Med J Aust 1985; 143(10):436-40.
6. King H, Rewers M. Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. WHO Ad Hoc Diabetes Reporting Group. Diabetes care. 1993; 16(1):157-77.
7. Selvin E, Coresh J, Brancati FL. The burden and treatment of diabetes in elderly individuals in the US. Diabetes care. 2006; 29(11):2415-9.
8. Larijani B, Abolhasani F, Mohajeri MR, Tabtabaei O. Prevalence of diabetes mellitus in Iran in 2000. Iranian Journal of Diabetes and Lipid Disorders. 2005; 4(3):75-83.
9. Abolhasani F, Mohajeri MR, Tabtabaei O, Larijani B. Burden of diabetes and its complications in Iran in year 2000. Iranian Journal of Diabetes and Lipid Disorders. 2005; 5(1):35-48.
10. Azizi F, Emami H, Salehi P, Ghanbarian A, Mirmiran P, Mirbolooki M, et al. Cardiovascular risk factors in the elderly: the Tehran Lipid and Glucose Study. Eur J Cardiovasc Prev Rehabil. 2003; 10(1):65-73.
11. Dorosty AR, Alavi Naeini AM. Correlation of elderly nutritional status with cardiovascular disease and diabetes. Tehran University Medical Journal 2007; 65(3): 68-71.
12. Hosseini SR, Zabihi A, Savadkohi S, Bijani A. Prevalence of chronic disease in elderly population in Amirkola (2006-2007). Journal of Babol University of Medical Sciences. 2008; 10(2):68-75.
13. Pellegrini F, Belfiglio M, De Berardis G, Franciosi M, Di Nardo B, Greenfield S, et al. Role of organizational factors in poor blood pressure control in patients with type 2 diabetes: the QuED Study Group-quality of care and outcomes in type 2 diabetes. Arch Intern Med. 2003; 163(4):473-80.
14. Antonopoulos S. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation. 2002; 106:3143-421.
15. Chuang LM, Tsai ST, Huang BY, Tai TY. The status of diabetes control in Asia--a crosssectional survey of 24 317 patients with diabetes mellitus in 1998. Diabet Med. 2002; 19(12):978-85.
16. Delavari A, Alikhani S, Nili S, Birjandi RH, Birjandi F. Quality of care of diabetes mellitus type II patients in Iran. Arc Iranian Med 2009; 12(5): 492-5.
17. Khunti K. Use of multiple methods to determine factors affecting quality of care of patients with diabetes. Fam Pract. 1999; 16(5):489-94.
18. O'Connor PJ, Desai JR, Solberg LI, Rush WA, Bishop DB. Variation in diabetes care by age: opportunities for customization of care. BMC Fam Pract. 2003; 4(1):16
19. Chuang LM, Tsai ST, Huang BY, Tai TY. The current state of diabetes management in Taiwan. J Peripher Nerv Syst. 2002; 7(2):137.
20. Nagpal J, Bhartia A. Quality of diabetes care in the middle-and high-income group populace. Diabetes Care. 2006; 29(11):2341-8.
21. Glynn R, Monane M, Gurwitz J, Choodnovskiy I, Avorn J. Aging, comorbidity, and reduced rates of drug treatment for diabetes mellitus. J Clin Epidemiol. 1999; 52(8):781-90.
22. Brown A, Mangione C, Saliba D, Sarkisian C. Guidelines for improving the care of the older person with diabetes mellitus. 2003;51: 265-80.
23. Saaddine J, Engelgau M, Beckles G, Gregg E, Thompson T, Narayan K. A diabetes report card for the United States: quality of care in the 1990s. Ann Intern Med. 2002; 136(8):565-74.
24. Care S. Guidelines for improving the care of the older person with diabetes mellitus. California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders with Diabetes. J Am Geriatr Soc. 2003; 51(Suppl 5): S265-S280.
25. Blaum C, Ofstedal M, Langa K, Wray L. Functional status and health outcomes in older Americans with diabetes mellitus. J Am Geriatr Soc. 2003; 51(6):745-53.
26. Lasker RD. The Diabetes Control and Complications Trial-Implications for Policy and Practice. N Engl J Med. 1993; 329(14):1035-6.
27. Hayden M. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)'. Lancet 1998; 352:837-53.
28. UKPDS Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317:703-13.
29. Goldberg R, Mellies M, Sacks F, Moye L, Howard B, Howard W, et al. Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. Circulation 1998; 98:2513-9.
30. Pyörälä K, Pedersen T, Kjekshus J, Faergeman O, Olsson A, Thorgeirsson G. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes care 1997; 20(4):614-20.
31. Grant RW, Buse JB, Meigs JB. Quality of diabetes care in US academic medical centers. Diabetes care. 2005; 28(2):337-42.
32. Saaddine JB, Cadwell B, Gregg EW, Engelgau MW, Vinicor F, Imperatore G, et al. Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002. Ann Intern Med. 2006; 144(7):465-74.
33. Lee W, Lim H, Thai A, Chew W, Emmanuel S, Goh L, et al. A window on the current status of diabetes mellitus in Singapore-the Diabcare-Singapore 1998 study. Singapore Med J 2001; 42(11):501-7.
34. Raheja BS, Kapur A, Bhoraskar A, Sathe SR, Jorgensen LN, Moorthi SR, et al. DiabCare Asia--India Study: diabetes care in India--current status. J Assoc Physicians India 2001; 49:717-22.
35. Liebl A, Mata M, Eschwege E. Evaluation of risk factors for development of complications in Type II diabetes in Europe. Diabetologia 2002; 45(7):23-8.
36. Narayan KM, Gregg EW, Engelgau MM, Moore B, Thompson TJ, Williamson DF, et al. Translation research for chronic disease: the case of diabetes. Diabetes care. 2000; 23(12):1794-8.
37. De Berardis G, Pellegrini F, Franciosi M, Belfiglio M, Di Nardo B, Greenfield S, et al. Quality of care and outcomes in type 2 diabetic patients. Diabetes care. 2004; 27(2):398-406.
38. Chin MH, Auerbach SB, Cook S, Harrison JF, Koppert J, Jin L, et al. Quality of diabetes care in community health centers. Am J Public Health. 2000; 90(3):431-4.